Rationale: HenochCSch?nlein purpura (HSP) is a small-vessel vasculitis that is extensively studied in children, but little is known about its natural history in adults. of HSP in children is estimated to be 15/100,000 cases. The proportion of males and females Voriconazole (Vfend) in children is close to 2:1. By comparison, it is more rare in adults with an estimated annual incidence of just one 1.3/100,000 cases. Weighed against HSP in kids, HSP in adults have significantly more serious clinical manifestations and worse outcomes. Clinical features of HSP consist of abdominal discomfort, gastrointestinal blood loss, nonthrombocytopenic palpable purpura, arthritis, and renal involvement. Most of them occur in autumn and winter, but its pathogenesis and causes are still unclear. In 2006, the diagnostic criteria published by the European League against Rheumatism and the Paediatric Rheumatology European Society which include palpable purpura in combination with at least one of other manifestations (ie, abdominal pain, immunoglobulin A deposition, arthritis or arthralgia, and renal involvement). There is no consensus on treatment of glucocorticoid for HSP in adults. The efficacy of glucocorticoid in preventing from severe complications or relapse is also controversial in HSP.[8,9] In this case Voriconazole (Vfend) report, we showed that an adult patient with HSP presenting with abdominal pain and gastrointestinal bleeding had a good response by glucocorticoid. 2.?Case presentation On February 12, 2019, a 20-year-old male was admitted to our department due to abdominal pain for more than 20 days, hematochezia for more than 10 days, and rash for 2 days. His disease course was as follows. On January 23, 2019, the patient presented with sudden onset of abdominal pain with nausea, vomiting, and fatigue but without hematemesis or melena. On January 28, 2019, he received symptomatic treatment at his local hospital. On February 2, 2019, he had hematochezia which presented with dark red pasty stool 4 times a day with an amount of about 50 mL every time. On February 10, 2019, he developed diffuse purpura on his limbs which were not faded by pressing. He was treated with symptomatic treatment without glucocorticoid. On February 11, 2019, he was transferred to our hospital. Laboratory tests showed the followings with normal range in parentheses: white blood cell (WBC), 38.4??109/L (3.5C9.5??109/L); percentage of granulocyte (GR%), 89.9% (40C75%); platelet count (PLT), 465??109/L (100C300??109/L); gamma-glutamyl transpeptidase (GGT), 82.79?U/L (8C78?U/L); carbohydrate antigen 125, 74.76?U/mL (0C35?U/mL); and serum sodium, 132.0?mmol/L (137C147?mmol/L). Abdominal color Doppler CD3D ultrasound showed cholestasis and cholecystitis. Chest and abdominal computed tomography scans showed localized thickening of small intestinal wall in the proper lower abdomen, handful of pericardial effusion, pelvic effusion, and abdominal lymph node enhancement (Fig. ?(Fig.11). Open up in another windowpane Shape 1 Upper body and abdominal CT on Feb 11, 2019. Panel A, Localized thickening of small intestinal wall in the right lower abdomen (red arrow). Panel B, A small amount of pericardial effusion (red arrow). Panel C, Pelvic effusion (red arrow). Panel D, Abdominal lymph node enlargement (red arrow). CT = computed tomography. On February 12, 2019, he was admitted to our department. His previous medical history included haemorrhoidectomy. Physical examinations showed soft abdomen, deep tenderness in the middle abdomen without rebound pain, and diffuse purpuric rashes on his limbs. Laboratory tests demonstrated WBC, 30.4??109/L; GR%, 89.5%; reddish colored bloodstream cell (RBC), 4.16??1012/L (4.3C5.8??1012/L); hemoglobin (Hb), 120?g/L (130C175?g/L); C-reactive proteins (CRP), 25.68?mg/L (10?mg/L); hematocrit, Voriconazole (Vfend) 35.8% (40%C50%); and PLT, 327??109/L. Fecal occult bloodstream check was positive. Electrocardiogram demonstrated sinus tachycardia. Consequently, based on the Western Little league against Rheumatism as well as the Paediatric Rheumatology Western Society requirements in 2006, HSP was diagnosed. He was treated with somatostatin 3000 initially? pantoprazole and g sodium 40?mg. On 13 February, 2019, the individual got deep red bloody stool again with the quantity of about 400 mL twice. His heartrate was about 125 beats each and every minute. Lab tests demonstrated WBC, 34.3??109/L; GR%, 88.5%; RBC, 4.66??1012/L; Hb, 135?g/L; erythrocyte sedimentation price (ESR), 22?mm/h (0C15?mm/h); CRP, 39?mg/L; PLT, 403??109/L; albumin, 23.1?g/L (40C55?g/L); serum calcium mineral (Ca), 1.97?mmol/L (2.08C2.6?mmol/L); procalcitonin, 0.281?ng/mL (0C0.05?ng/mL); D-dimer, 24.11?mg/L; immunoglobulin A, 3.20?g/L (0.7C4?g/L); immunoglobulin G, 8.47?g/L (7C16?g/L); immunoglobulin M, 0.37?g/L (0.4C2.3?g/L); go with C3, 1.081?g/L (0.75C1.55?g/L); and go with C4, 0.185?g/L (0.1C0.4?g/L). Hepatitis B and C virus were negative. A dermatologist’s consultation suggested discontinuation of suspected drugs, oral use of desloratadine 5?mg/d, ebastine 20?mg/d, and melilotus extract tablets 3600?mg/d, external use of.